Related references
Note: Only part of the references are listed.Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Development of the autoinflammatory disease damage index (ADDI)
Nienke M. Ter Haar et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Spondyloarthritis associated with familial Mediterranean fever: successful treatment with anakinra
Sophie Georgin-Lavialle et al.
RHEUMATOLOGY (2017)
A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
Alice Corsia et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments
Seza Ozen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Non-response to colchicine in familial Mediterranean fever should be identified accurately
Meltem A. Melikoglu et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
EULAR recommendations for the management of familial Mediterranean fever
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Approach to the patients with inadequate response to colchicine in familial Mediterranean fever
Ahmet Gul
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2016)
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever
Gabriella Giancane et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Erythrocyte sedimentation rate and C-reactive protein
Michael Harrison
AUSTRALIAN PRESCRIBER (2015)
Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
D Konukbay et al.
Pediatric Rheumatology (2015)
Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle/Black Sea Region of Turkey (in Çorum region)
Y Karaaslan et al.
Pediatric Rheumatology (2015)
Acute phase reactants in the follow-up of patients with FMF
ZS Arıcı et al.
Pediatric Rheumatology (2015)
Underlying causes of persistently elevated acute phase reactants in patiens with Familial Mediterranean Fever
R Mercan et al.
Pediatric Rheumatology (2015)
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
Fehime Kara Eroglu et al.
RHEUMATOLOGY INTERNATIONAL (2015)
FMF50: a score for assessing outcome in familial Mediterranean fever
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Evidence-based recommendations for the practical management of Familial Mediterranean Fever
Veronique Hentgen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Incomplete response to colchicine in M694V homozygote FMF patients
Merav Lidar et al.
AUTOIMMUNITY REVIEWS (2012)
Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review
Rym Boulkedid et al.
PLOS ONE (2011)
Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement
Tilmann Kallinich et al.
PEDIATRICS (2007)
Colchicine nonresponsiveness in familial Mediterranean fever: Clinical, genetic, pharmacokinetic, and socioeconomic characterization
M Lidar et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Colchicine treatment in children with familial Mediterranean fever
N Özkaya et al.
CLINICAL RHEUMATOLOGY (2003)
Share Paper
